u/Fancy-Supermarket-73

To my fellow FSHDers, some good news—unless someone else has already posted it.

The main link worth reading:

https://investorrelations.sarepta.com/static-files/7de668c5-4a60-440c-8dd9-22884fd57703

It absolutely blows Avidity’s intracellular concentration and DUX4 reduction results out of the water.

Phase 2 enrolment is expected to begin in late 2026 (october) or early 2027:

https://www.sarepta.com/community-letter-update-fshd1-clinical-development-program